UPDATE : Monday, September 7, 2020
상단여백
Sanofi to test new diabetic drug in phase-3 study
Sanofi-Aventis Korea said it would start phase-3 clinical trials (SAR439954...
by Lee Hye-seon  |  2018-04-26 14:40
라인
‘Switching Tylenol ER to prescription drug unnecessary’
Local pharmaceutical experts said the health authorities did not have to sw...
by Lee Hye-seon  |  2018-04-25 16:06
라인
Patent requests for brain-controlled wheelchairs surge
Patent applications for smart wheelchairs using brain-machine interface (BM...
by Lee Hye-seon  |  2018-04-20 15:46
라인
Seoul to simplify orphan drug designation
The Ministry of Food and Drug Safety (MFDS) on Wednesday said it would amen...
by Lee Hye-seon  |  2018-04-19 16:00
라인
Exhibition showcases latest pharma products, trends
An international pharmaceutical exhibition opened at the Korea Internationa...
by Lee Hye-seon  |  2018-04-17 16:14
라인
Dental implants drove up output growth of medical devices in 2017
Korea’s output of medical devices expanded 3.9 percent year-on-year to mark...
by Lee Hye-seon  |  2018-04-17 11:48
라인
Janssen Korea launches new psoriasis treatment
Janssen Korea said it has launched a follow-up drug of psoriasis treatment ...
by Lee Hye-seon  |  2018-04-16 11:48
라인
Hanmi gives up on lung cancer drug Olita
Hanmi Pharmaceutical is expected to discontinue developing lung cancer trea...
by Lee Hye-seon  |  2018-04-13 11:00
라인
LG Chem works on 3-in-1 combo for hypertension
LG Chem said it has won approval from the Ministry of Food and Drug Safety ...
by Lee Hye-seon  |  2018-04-12 16:32
라인
Il-yang’s ‘Supect’ loses 2nd indication for leukemia
The government said Tuesday Il-yang Pharmaceutical’s Supect (ingredient: ra...
by Lee Hye-seon  |  2018-04-10 15:14
라인
Filler study plans won the most approvals in 2017
Medical device manufacturers’ plans for clinical trials on filler developme...
by Lee Hye-seon  |  2018-04-04 14:55
라인
Seoul orders Janssen to fill up PMS cases to 3,000
Janssen Korea will have to increase the number of post-marketing surveillan...
by Lee Hye-seon  |  2018-04-02 16:30
라인
Heavy ion cancer therapy to arrive in Korea in 2022
Korean cancer patients will be able to receive a state-of-the-art heavy ion...
by Lee Hye-seon  |  2018-03-30 15:17
라인
Hanmi wins nod to test antihypertensive cocktail of 4 drugs
Hanmi Pharmaceutical has obtained approval to test a combination therapy of...
by Lee Hye-seon  |  2018-03-28 17:19
라인
Seoul OKs plan to test systemic sclerosis drug Lenabasum
The pharmaceutical industry is paying attention to whether Lenabasum, an in...
by Lee Hye-seon  |  2018-03-27 11:36
라인
Local drugmakers poor at winning nod for clinical trials
Samsung Medical Center obtained the most approvals for clinical trials in t...
by Lee Hye-seon  |  2018-03-23 12:04
라인
Jointstem fails to win conditional nod
Jointstem, a stem cell therapy for degenerative arthritis, failed to obtain...
by Lee Hye-seon  |  2018-03-19 12:12
라인
Locally developed surgical robot unveiled
Revo-i, the first locally developed laparoscopic surgical robot, is about t...
by Lee Hye-seon  |  2018-03-15 15:24
라인
Hepatitis B recurrence warning on anticancer drugs by Jeil, Myungmoon
The government said it would order Jeil Pharmaceutical and Myungmoon Pharm ...
by Lee Hye-seon  |  2018-03-13 11:47
라인
Clzapine warnings to add obesity, fall
The government has ordered Dongwha Pharm, regarding its Clzapine Tab. (ingr...
by Lee Hye-seon  |  2018-03-09 14:24
여백
여백
여백
Back to Top